InvestorsHub Logo
Followers 0
Posts 450
Boards Moderated 0
Alias Born 11/08/2013

Re: None

Monday, 11/11/2013 4:51:50 PM

Monday, November 11, 2013 4:51:50 PM

Post# of 92246
A cursory check of outstanding shares is somewhere in the neighborhood of 350,000,000 after the 62,500,000 additional shares added which was released on Friday as part of the warrant conversion.

Can the explosive growth in outstanding shares continue to fund operations?

Why would anyone wish to hold or purchase uncollateralized common shares when losses are expected to grow with expanding attempts at marketing and distribution?

Taken directly from the most recent 10-K:

The net loss for the nine months ended June 30, 2013 was $(8,944,785).

At June 30, 2013, the Company had cash of approximately $380,215 and a working deficit of $(17,803). Further, at June 30, 2013, the accumulated deficit amounted to $32,058,829. As a result of the Company's history of losses and unfavorable financial condition, there is substantial doubt about the ability of the Company to continue as a going concern.

Now Angel Investors or current Rule 13D shareholders (call them what you may) want to fund the losses with $4 million more cash converted to more stock? Is that the story some are telling on this thread?

That would be very generous of them to 100% fund $4 million at no cost to you "your" existing investment in Fuse Science if you are a common shareholder to simply be diluted. They must be very generous men indeed.